Holen Sie sich die Stockscreener-App
3.94
1.62%
-0.07
Schlusskurs vom Vortag:
$4.01
Offen:
$3.94
24-Stunden-Volumen:
4,572
Relative Volume:
0.01
Marktkapitalisierung:
$212.78M
Einnahmen:
$77.36M
Nettoeinkommen (Verlust:
$-38.43M
KGV:
-5.3186
EPS:
-0.7408
Netto-Cashflow:
$-29.92M
1W Leistung:
-27.08%
1M Leistung:
-28.66%
6M Leistung:
+8.98%
1J Leistung:
+41.40%
1-Tages-Spanne:
$3.94
$3.945
1-Wochen-Bereich:
$3.57
$4.8674
52-Wochen-Spanne:
$2.03
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Firmenname
Sight Sciences Inc
Sektor
Branche
Telefon
(415) 889-0550
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.94 | 220.88M | 77.36M | -38.43M | -29.92M | -0.7408 |
|
ABT
Abbott Laboratories
|
110.14 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.22 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.94 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.86 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.24 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | Hochstufung | Lake Street | Hold → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-11-04 | Herabstufung | Lake Street | Buy → Hold |
| 2024-08-21 | Eingeleitet | Lake Street | Buy |
| 2023-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2022-10-04 | Eingeleitet | Needham | Hold |
| 2022-07-26 | Eingeleitet | Stifel | Hold |
| 2022-02-03 | Eingeleitet | William Blair | Outperform |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Sight Sciences (SGHT) Q4 2025 Earnings Transcript - AOL.com
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2025 earnings call transcript - MSN
Sight Sciences Earnings Call Highlights Disciplined Growth - TipRanks
Stock Report: Can Sight Sciences Inc weather a recession2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn
Sight Sciences, Inc. (SGHT) reports Q4 loss, beats revenue estimates - MSN
S P Trends: Will Sight Sciences Inc outperform tech stocks2025 Bull vs Bear & Long-Term Safe Investment Ideas - baoquankhu1.vn
Sight Sciences Shareholders Are Encouraged to Reach Out to - GlobeNewswire
Sight Sciences (NASDAQ:SGHT) Price Target Cut to $11.00 by Analysts at UBS Group - MarketBeat
Sight Sciences (NASDAQ:SGHT) Price Target Lowered to $6.50 at Citigroup - MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2025 Earnings Call Transcript - Insider Monkey
Sight Sciences Reports Preliminary Fourth Quarter 2025 Revenue Growth, Provides 2026 Outlook - VisionMonday.com
Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy - MSN
William Blair Maintains Outperform on SGHT Sight Sciences, Inc. March 2026 - Meyka
Sight Sciences (SGHT) EPS Loss Narrows Again And Tests Bearish Profitability Narratives - simplywall.st
William Blair reiterates Sight Sciences stock rating on expense control - Investing.com Nigeria
William Blair reiterates Sight Sciences stock rating on expense control By Investing.com - Investing.com India
Sight Sciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Sight Sciences Q4 Net Loss Narrows; Expects 6-14% Revenue Growth In FY26 - Nasdaq
Sight Sciences sees FY26 revenue $82M-$88M, consensus $86.11M - TipRanks
Sight Sciences Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Sight Sciences beats Q4 2025 forecasts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: Sight Sciences beats Q4 2025 forecasts, stock rises - Investing.com Nigeria
Sight Sciences Q4 Earnings Call Highlights - MarketBeat
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates - Bitget
Sight Sciences (SGHT) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Sight Sciences reports Q4 EPS (8c), consensus (14c) - TipRanks
Sight Sciences Q4 Loss Narrows, Revenue Rises - marketscreener.com
Sight Sciences Inc. (SGHT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Sight Sciences (NASDAQ:SGHT) Posts Quarterly Earnings Results - MarketBeat
Sight Sciences Q4 Earnings Assessment - Benzinga
Sight Sciences Posts Q4 Growth, Issues 2026 Outlook - TipRanks
SGHT: OMNI and TearCare drive innovation in eyecare, targeting large, underserved markets - TradingView
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance - The Manila Times
Sight Sciences (SGHT) outlines interventional glaucoma and dry eye growth plan - Stock Titan
Sight Sciences (NASDAQ: SGHT) narrows 2025 loss and targets 6–14% growth - Stock Titan
Eye-care firm Sight Sciences targets up to 14% 2026 growth after $38M 2025 loss - Stock Titan
SGHT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Uncovering Potential: Sight Sciences's Earnings Preview - Benzinga
5 Analysts Assess Sight Sciences: What You Need To Know - Sahm
Stifel raises Sight Sciences stock price target on TearCare survey By Investing.com - Investing.com Canada
Stifel Nicolaus Issues Positive Forecast for Sight Sciences (NASDAQ:SGHT) Stock Price - MarketBeat
Stifel raises Sight Sciences stock price target on TearCare survey - Investing.com
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
SGHT SEC FilingsSight Sciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Sight Sciences (NASDAQ:SGHT) Has Debt But No Earnings; Should You Worry? - 富途牛牛
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Finviz
Sight Sciences, Inc. (SGHT) Projected to Surpass Earnings Predictions: Will the Share Price Rise? - Bitget
Sight Sciences (SGHT) Projected to Post Quarterly Earnings on Wednesday - Defense World
[Form 4] Sight Sciences, Inc. Insider Trading Activity - Stock Titan
Should you avoid Sight Sciences Inc. stock right nowJuly 2025 Rallies & Precise Buy Zone Identification - mfd.ru
Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times
Finanzdaten der Sight Sciences Inc-Aktie (SGHT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):